Reverse DCF
What growth does the market imply for SYNGENE?
Working backwards from the current price to find the FCF growth assumption baked in.
reasonable
11.1% implied annual FCF growth
The market's growth assumption looks achievable for a quality business. This is within normal range — the stock is not pricing in heroic execution.
Current Price
₹454
Historical Growth
0.4%
FCF Yield
3.42%
Price / FCF
29.2x
Plain English
To justify today's price of ₹453.50, SYNGENE.NS needs to grow its free cash flow at 11.1% per year for the next 10 years. That is 10.7% faster than its historical growth rate of 0.4%. This looks achievable — the market is not pricing in heroic assumptions. There may be genuine upside if the company executes.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Historical | 0.4% | ₹193 | -57.3% |
| Half implied | 5.6% | ₹292 | -35.5% |
| GDP rate | 10.0% | ₹417 | -8.0% |
| Implied | 11.1% | ₹454 | +0.0% |
At Historical Growth Rate
DCF horizon: 10 years. At 0.4% growth, the model values SYNGENE at ₹193, below today's ₹454.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, reverse DCF, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.